This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Valeant Pharmaceuticals International, Inc.
Drug Names(s): clindamycin phosphate 1.2% and benzoyl peroxide 2.5%
Acanya Gel is a combination product that contains 1% clindamycin (clindamycin phosphate 1.2%) and benzoyl peroxide 2.5%. Clindamycin is an antibiotic with the activity against the Propionibacterium acnes (P acnes). Bezoyl peroxide is an antibacterial agent that is active against P acnes based on its oxidizing properties.
Another formulation of this product, Onexton (clindamycin phosphate 1.2% and benzoyl peroxide 3.75%), was approved in 2014.
Acanya Gel was originally developed by Dow Pharmaceutical Sciences.
In December 2008, Valeant announced that it has signed a definitive agreement to acquire Dow Pharmaceutical Sciences. Dow Pharmaceutical will operate as a wholly owned subsidiary of Valeant.
Acanya Gel News
Additional information available to subscribers only: